Extension Study of AGT-181-102 to Evaluate Long Term Safety and Activity of AGT-181
NCT02597114
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
3
Enrollment
INDUSTRY
Sponsor class
Conditions
Mucopolysaccharidosis I
Interventions
DRUG:
AGT-181
Sponsor
ArmaGen, Inc